Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Looking to improve outcomes for patients with advanced COPD/emphysema? This free Medscape CME provides practical guidance on identifying and supporting candidates for endobronchial valve treatment. | Pulmonx | Facebook

Chronic Myeloid Leukemia: Harmonizing Clinical Trial Data With Clinical Practice | Medscape

Narcolepsy Is More Common Than You Think: Identifying Patients With Type 1 Narcolepsy in Primary Care | Medscape

Game-Changing Developments in Hypertrophic Cardiomyopathy: Rapid-Fire Insights | Medscape

What are the key takeaways from the Heart Failure Society of America’s (HFSA) Annual Scientific Meeting 2025? Join Drs Martha Gulati and Anuradha Lala-Trinidade for a live social media event as they review the top late-breaking data across the spectrum of heart failure, sharing their expert insights on how these developments could influence clinical practice and patient care - - - - - Faculty: ​​​​Martha Gulati, MD, MS Faculty: ​​​​Anuradha Lala-Trindade, MD - - - - - Earn free 0.25 AMA PRA Cate